Clinical trial

Chinese Multiple Dose Escalation (MDE) High Dose Study

NCT05437848

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-02-25

PhasePHASE1

Study timeline

Study start (actual)2022-02-25Date precision: day

Registry last updated2023-11-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

Experimental: CotadutideDRUG

PlaceboOTHER

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

GuangzhouChina1 NanjingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05437848 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.